Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ALLOGENE THERAPEUTICS, INC.

(ALLO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart ALLOGENE THERAPEUTICS, INC.
Upcoming events on ALLOGENE THERAPEUTICS, INC.
03/11/22 FY 2021 Earnings Release (Projected)
05/11/22 Q1 2022 Earnings Release (Projected)
08/10/22 Interim 2022 Earnings Release (Projected)
11/09/22 Q3 2022 Earnings Release (Projected)
Past events on ALLOGENE THERAPEUTICS, INC.
01/11/22 | 03:45pm JP Morgan Healthcare Conference
01/10/22 | 11:30am Business Update Call
12/13/21 | 06:00pm American Society of Hematology Virtual Meeting and Exposition - Abstract No #3878
12/13/21 | 04:30pm American Society of Hematology Virtual Meeting and Exposition - ALPHA, ALPHA2 and UNIVERSAL
12/13/21 | 11:00am American Society of Hematology Virtual Meeting and Exposition - Abstract No #651
12/13/21 | 10:30am American Society of Hematology Virtual Meeting and Exposition - Abstract No #649
12/06/21 | 03:00pm JMP Securities Hematology and Oncology Summit
11/30/21 | 03:30pm Evercore ISI HealthCONx Conference
11/18/21 | 03:00am Jefferies London Healthcare Conference
11/16/21 | 02:00pm Stifel Healthcare Conference
Past dividends on ALLOGENE THERAPEUTICS, INC.

- No events available -

Annual results
Fiscal Period : December20172018201920202021
Sales
M $
Released
Forecast
Spread


 


 


 


 
 
38,4
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread


 
-191
-192
0,50%
-198
-204
3,0%
-251
-250
-0,51%
 
-258
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread


 
-193
-192
-0,54%
-202
-210
3,9%
-258
-263
1,8%
 
-266
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread


 
-212
-203
-4,5%
-185
-195
5,4%
-250
-257
2,7%
 
-265
 
Net income
M $
Released
Forecast
Spread
0,00

 
-212
-205
-3,0%
-185
-195
5,5%
-250
-257
2,6%
 
-265
 
EPS
$
Released
Forecast
Spread


 
-7,31
-6,53
-12%
-1,83
-1,94
5,8%
-2,08
-2,14
2,7%
 
-1,97
 
Announcement Date08/10/201803/08/201902/27/202002/25/2021-
Quarterly results
Fiscal Period : December2020 Q32020 Q42021 Q12021 Q22021 Q32021 Q4
Sales
M $
Released
Forecast
Spread


 


 
38,3
11,9
221%
0,04
0,26
-83%
0,05

 
 
0,01
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-66,2
-66,0
-0,35%
-67,5
-69,9
3,4%
-31,3
-73,9
58%
-69,1
-71,9
4,0%
-75,3
-77,5
2,8%
 
-83,1
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-68,0
-69,6
2,2%
-69,4
-76,5
9,4%
-33,2
-60,9
45%
-71,0
-74,8
5,0%
-77,7
-77,9
0,35%
 
-83,6
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-66,2
-67,2
1,6%
-68,6
-75,7
9,4%
-33,0
-59,6
45%
-70,9
-73,0
2,8%
-78,2
-76,4
-2,3%
 
-82,4
 
Net income
Released
Forecast
Spread
-66,2
-67,2
1,6%
-68,6
-75,4
9,0%
-33,0
-60,6
46%
-70,9
-73,0
2,9%
-78,2
-76,7
-2,0%
 
-82,4
 
EPS
Released
Forecast
Spread
-0,52
-0,55
5,5%
-0,53
-0,58
9,0%
-0,25
-0,46
46%
-0,53
-0,55
3,2%
-0,57
-0,56
-1,3%
 
-0,60
 
Announcement Date11/04/202002/25/202105/05/202108/04/202111/04/2021-
Previous year Next Year
Upcoming sector events for ALLOGENE THERAPEUTICS, INC.
More events
Past sector events for ALLOGENE THERAPEUTICS, INC.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise